Tango Therapeutics (TNGX) Asset Utilization Ratio (2021 - 2026)

Tango Therapeutics' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.14 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 1.57% year-over-year to 0.14 in Q1 2026; TTM through Mar 2026 was 0.14, a 1.57% decrease from a year earlier, with the FY2025 full-year figure at 0.17, up 49.09% from the prior year.
• Asset Utilization Ratio retreated to 0.14 in Q1 2026 per TNGX's latest filing, from 0.2 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.3 in Q3 2025 and bottomed at 0.05 in Q2 2022.
• The 5-year median for Asset Utilization Ratio is 0.09 (2023), against an average of 0.11.
• Across the five-year window, Asset Utilization Ratio plunged 79.1% in 2022 and soared 151.08% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.06 in 2022, then jumped by 59.29% to 0.09 in 2023, then surged by 43.04% to 0.13 in 2024, then surged by 62.92% to 0.2 in 2025, then sank by 33.35% to 0.14 in 2026.
• Per Business Quant, the three latest TNGX Asset Utilization Ratio figures stand at 0.14 (Q1 2026), 0.2 (Q4 2025), and 0.3 (Q3 2025).